{"title":"Breaking the commandments: feasibility and medium-term outcome of Fontan procedure in patients with high preoperative mean pulmonary artery pressure.","authors":"Deepali Bangalia, Rajarshi Ghosh, Somrita Laha, Joshi Siddhartha, Hemanta Kumar Nayak, Srikant Sharma, Rahul Bose, Sudipta Bhattacharjya, Arnab Paul, Srirup Chatterjee, Satyajit Bose","doi":"10.1007/s12055-026-02225-5","DOIUrl":"10.1007/s12055-026-02225-5","url":null,"abstract":"<p><strong>Background: </strong>The Fontan procedure is the final common pathway of single ventricle palliation. Over the years, there has been much evolution in the technique of the Fontan procedure and the so-called Ten Commandments to guide the selection of a classic patient for successful Fontan completion. We present our experience of operating on patients with > 15 mm Hg preoperative mean pulmonary artery pressure (mPAP).</p><p><strong>Methods: </strong>A retrospective analysis was carried out to identify patients with a mPAP > 15 mm Hg who underwent Fontan completion between January 2014 and December 2024 in our institute.</p><p><strong>Results: </strong>A total of 159 patients underwent Fontan surgery during this time period. Of them, 18 (11.3%) patients had a mPAP > 15 mm Hg; 13 (72.2%) had mPAP 16-18 mm Hg, and 5 (27.8%) had mPAP > 18 mm Hg. The median age at Fontan surgery was 14.9 years. Mean duration of postoperative intensive care unit (ICU) stay was 2 (± 0.8) days, and mean duration of hospital stay was 10 (± 3.1) days. Pulmonary vasodilators were used to treat 5 (27.8%) patients before the completion of Fontan; all 18 patients had postoperative pulmonary vasodilator therapy continued for 6-12 weeks. One patient expired (mortality 5.6%) due to postoperative overwhelming sepsis. There was no readmission. The mean duration of follow-up was 4.1 years.</p><p><strong>Conclusion: </strong>Carefully selected patients with elevated preoperative mPAP and acceptable Pulmonary Vascular Resistance Index (PVRI) can undergo Fontan completion with satisfactory early and medium-term outcomes.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 10","pages":"1127-1133"},"PeriodicalIF":0.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13594033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Double-outlet right atrium (DORA) associated with dextro-transposition of the great arteries with intact ventricular septum (d-TGA-IVS): an unusual atrioventricular junction variant.","authors":"Sathaiah Dadi, Krishnan Ganapathy Subramaniam, Bhargavi Dhulipudi, Shweta Nathani Bakhru, Nageshwara Rao Koneti, Zineb El Hasanaoui","doi":"10.1007/s12055-026-02238-0","DOIUrl":"10.1007/s12055-026-02238-0","url":null,"abstract":"<p><p>Dextro-transposition of the great arteries with intact ventricular septum (d-TGA-IVS) typically requires neonatal repair, as regression of left ventricular (LV) mass and compliance may limit the feasibility of delayed anatomical correction. Survival beyond the neonatal period without intervention is uncommon and usually reflects additional shunt lesions or atypical intracardiac physiology. Double-outlet right atrium (DORA) is a rare atrioventricular (AV) junction malalignment in which the right atrium (RA) drains into both ventricles through separate AV valve orifices, resulting in abnormal atrial-level streaming. We report a 40-day-old infant with d-TGA-IVS who presented with heart failure and intraoperative findings revealed a complex AV junction anatomy with three distinct AV valve orifices consistent with DORA physiology. A tailored biventricular repair consisting of arterial switch operation (ASO) and atrial-level reconstruction was performed to preserve unobstructed LV inflow in the presence of a borderline mitral valve (MV). At mid-term follow-up, ventricular function was preserved, LV inflow remained unobstructed, and interval growth of the native MV was observed. This case highlights the importance of recognizing atypical AV junction anatomy and flow-dependent physiology in d-TGA-IVS, as these factors may influence clinical presentation and surgical strategy.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 10","pages":"1169-1174"},"PeriodicalIF":0.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13594070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jason H Yan, Joseph McKinnerney, Bree Cattelino, Rhian E Davies, Rahul Kashyap
{"title":"Impact of prior congenital heart surgery on coronary artery bypass grafting outcomes in adults with congenital heart disease.","authors":"Jason H Yan, Joseph McKinnerney, Bree Cattelino, Rhian E Davies, Rahul Kashyap","doi":"10.1007/s12055-026-02246-0","DOIUrl":"10.1007/s12055-026-02246-0","url":null,"abstract":"<p><strong>Background: </strong>The long-term impact of prior congenital heart disease (CHD) surgeries on adult cardiac surgery outcomes remains underexplored. Our study evaluates the influence of prior congenital heart interventions on postoperative outcomes in adult patients undergoing cardiac surgery.</p><p><strong>Method: </strong>We conducted a retrospective cohort study using the TriNetX database, analyzing adults with repaired CHD who later underwent coronary artery bypass grafting (CABG). This cohort was then compared to age-, gender-, race-, ethnicity-, comorbidity-, medication-, and CHD diagnosis-matched controls of patients with unrepaired CHD requiring CABG in adulthood. After propensity score matching, each group included 1425 individuals.</p><p><strong>Results: </strong>After matching, there were no statistically significant differences in baseline characteristics. Patients with a history of prior CHD surgical repair had significantly lower odds of 30-day all-cause mortality (odds ratio [OR] 0.33, 95% confidence interval [CI] 0.21-0.52, <i>p</i> < 0.01). However, this group also showed increased odds of hospital readmission within 30 days (OR 1.33, 95% CI 1.14-1.54, <i>p</i> < 0.01). Secondary outcomes showed higher incidence of acute kidney injury (AKI) (OR 1.42, <i>p</i> < 0.01), pleural effusion (OR 1.33, <i>p</i> < 0.01), and cardiac arrhythmias (OR 1.52, <i>p</i> < 0.01) in the CHD-repaired group. No significant differences were observed for acute myocardial infarction (MI), stroke, transient ischemic attack (TIA), or need for reoperation.</p><p><strong>Conclusion: </strong>These results suggest that patients with prior CHD repairs can successfully undergo coronary revascularization later in life despite having a distinct postoperative risk profile. However, it may also predispose patients with repaired CHD to higher rates of certain postoperative complications, including arrhythmias, pleural effusion, and AKI.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 10","pages":"1117-1126"},"PeriodicalIF":0.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13594000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Solitary fibrous tumour presenting as a rare anterior mediastinal mass in an adult.","authors":"Arun Sharma, Mansi Verma, Ashish Dua, Amanjit Bal, Harkant Singh, Manphool Singhal","doi":"10.1007/s12055-026-02236-2","DOIUrl":"10.1007/s12055-026-02236-2","url":null,"abstract":"<p><p>Solitary fibrous tumours (SFTs) are a rare group of neoplasms of mesenchymal origin. We report a case of a 47-year-old male who was found to have an intensely enhancing large mass in the anterior mediastinum on contrast-enhanced computed tomography which was proved to be a SFT on histopathology.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 10","pages":"1180-1182"},"PeriodicalIF":0.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13594052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149024878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mahdi YazdFazeli, Sahar Samimi, Mohammad Abbasi Teshnizi, Hamid Hoseinikhah, Aliasghar Moeinipour, Omid Javedanfar, Vahid Ghavami, Farshad Abedi, Shahram Amini, Benyamin Fazli, Amir Hooshang Mohammadpour
{"title":"Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart valve surgery: a double-blind, randomized, placebo-controlled trial.","authors":"Mahdi YazdFazeli, Sahar Samimi, Mohammad Abbasi Teshnizi, Hamid Hoseinikhah, Aliasghar Moeinipour, Omid Javedanfar, Vahid Ghavami, Farshad Abedi, Shahram Amini, Benyamin Fazli, Amir Hooshang Mohammadpour","doi":"10.1007/s12055-026-02240-6","DOIUrl":"10.1007/s12055-026-02240-6","url":null,"abstract":"<p><strong>Background: </strong>Postoperative atrial fibrillation (POAF) commonly complicates heart valve surgery. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, may offer antiarrhythmic benefits. This trial evaluated its efficacy in preventing POAF.</p><p><strong>Methods: </strong>In a double-blind placebo-controlled trial, 110 patients undergoing elective heart valve surgery were randomized to oral empagliflozin 10 mg daily (<i>n</i> = 55) or placebo (<i>n</i> = 55) from 3 days pre-op to 3 days post-op. All patients received standard care. The primary analysis was performed in a modified intention-to-treat (mITT) population, defined as randomized patients with at least one assessable primary outcome measurement; 81 patients were included in the final mITT analysis. The primary outcome was POAF incidence within 72 h, assessed via continuous electrocardiography (ECG) monitoring. Secondary outcomes included other arrhythmias, C-reactive protein (CRP) levels, and glycemic control.</p><p><strong>Results: </strong>POAF occurred in 8 patients (20.0%) in the empagliflozin group and 16 patients (39.0%) in the placebo group, corresponding to a 49% relative risk reduction, although this difference did not reach statistical significance (<i>p</i> = 0.088). Empagliflozin was associated with non-significant reductions in ventricular tachycardia (2.5% vs. 14.6%, <i>p</i> = 0.109) and premature ventricular contractions (45.0% vs. 65.9%, <i>p</i> = 0.075). Postoperative blood glucose levels were significantly lower in the empagliflozin group on days 1 and 2 (<i>p</i> < 0.05). No significant differences were observed in postoperative CRP levels (<i>p</i> = 0.12) or adverse event rates, including hypoglycemia and infection.</p><p><strong>Conclusion: </strong>Short-term perioperative empagliflozin did not significantly reduce the incidence of POAF after heart valve surgery; however, the results suggest a possible reduction in POAF and improved postoperative glycemic control, without an apparent increase in adverse events in this selected, closely monitored population. These findings require confirmation in larger randomized trials.</p><p><strong>Graphical abstract: </strong></p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1023-1033"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Temporary femoro-femoral external shunt for lower-extremity malperfusion in acute type A aortic dissection.","authors":"Ryoi Okano, Dai Kawashima, Satoru Maeba","doi":"10.1007/s12055-026-02208-6","DOIUrl":"10.1007/s12055-026-02208-6","url":null,"abstract":"<p><p>Acute limb ischemia is a severe complication of acute type A aortic dissection (ATAAD). The optimal management strategy remains debated and is dependent on the clinical context. Herein, we report the case of a 58-year-old man with ATAAD complicated by right lower limb malperfusion. During the aortic root replacement, regional oxygen saturation (rSO2) of the lower extremities was monitored using near-infrared spectroscopy, which demonstrated an early decline in right limb rSO2. To achieve prompt reperfusion, a femoro-femoral external shunt from the left to the right common femoral artery was established, serving as a bridge for definitive femoro-femoral bypass. The postoperative course was uneventful, without any evidence of reperfusion syndrome or neurological deficits. Thus, in certain cases, an external shunt may provide an effective bridging strategy for limb ischemia, and a decrease in rSO2 may serve as an early indicator for immediate reperfusion.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1093-1097"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Bellido-Yarlequé, Roberto Baltodano-Arellano, Rossi Ramos-Isidro, Kevin Velarde-Acosta, Georgette Vetanzo-Sánchez, Jean Pool Cabello-Barron
{"title":"Valve-sparing surgery for right-sided endocarditis presenting as a giant right atrial mass in a hemodialysis patient.","authors":"David Bellido-Yarlequé, Roberto Baltodano-Arellano, Rossi Ramos-Isidro, Kevin Velarde-Acosta, Georgette Vetanzo-Sánchez, Jean Pool Cabello-Barron","doi":"10.1007/s12055-026-02203-x","DOIUrl":"10.1007/s12055-026-02203-x","url":null,"abstract":"<p><p>Tricuspid valve infective endocarditis (TVIE) is an uncommon form of right-sided endocarditis, typically associated with intravenous drug use or intravascular devices. Diagnosis is often delayed in immunocompromised patients, particularly those undergoing chronic hemodialysis (HD). We describe a 51-year-old woman with systemic lupus erythematosus (SLE), diabetes, and end-stage renal disease (ESRD) on chronic HD via a tunneled central venous catheter (TCVC). She presented with generalized weakness, hypotensive episodes during HD, and persistent fever. Blood cultures grew <i>Staphylococcus aureus</i>, and chest computed tomography (CT) revealed bilateral cavitary nodules consistent with septic pulmonary emboli. Transesophageal echocardiography (TEE) identified a 5 × 2.3-cm mobile and digitiform vegetation attached to the tricuspid valve, extending into the right atrium and superior vena cava (SVC). Despite targeted antibiotics, the infection persisted. Intraoperative findings revealed a 7-cm fibrous mass with a 3-cm calcified base adherent to the tricuspid valve, extending into the right atrium and causing near-total occlusion of the SVC. The mass was excised, and the native valve was successfully preserved. The postoperative course was uneventful. This case highlights the diagnostic and therapeutic complexity of TVIE in immunosuppressed dialysis patients. Surgical intervention was indicated due to persistent bacteremia, embolic complications, and large vegetations, in line with current European Society of Cardiology (ESC) guidelines. Notably, the native valve was preserved despite extensive intracardiac involvement, representing a favorable surgical outcome. Clinicians should maintain a high index of suspicion for right-sided endocarditis in dialysis patients presenting with respiratory or embolic symptoms.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02203-x.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1089-1092"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437840/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Successful repair of a rare submitral aneurysm with basal septal defect: a technique combining edge-to-edge repair and patch exclusion.","authors":"Gaurish Sawant, Balaji Aironi, Ayush Agarwal, Aishwarya Purohit, Rajat Lohiya, Hitesh Makhija","doi":"10.1007/s12055-026-02212-w","DOIUrl":"10.1007/s12055-026-02212-w","url":null,"abstract":"<p><p>Submitral left ventricular aneurysm (SLVA) is an exceedingly rare clinical entity associated with high mortality due to potential rupture, systemic embolism, and severe mitral regurgitation (MR). Surgical management is complex, necessitating strategies that address both the aneurysm and the valvular pathology while preserving ventricular geometry. We present the case of a 44-year-old male presenting with syncope and acute heart failure. Multi-modality imaging, including cardiac magnetic resonance imaging (MRI), revealed a large (7.4 × 6.9 cm) basal septal left ventricle (LV) aneurysm with a thick mural thrombus and severe MR secondary to anterior leaflet tethering. Coronary angiography ruled out ischemic etiology. Under cardiopulmonary bypass, the mitral valve was accessed via a paraseptal left atrial approach. An Alfieri stitch (edge-to-edge repair) was utilized to correct the leaflet prolapse, achieving competent coaptation. The aneurysm was approached externally; the cavity was incised, and the thrombus evacuated. The 2.5-cm aneurysmal neck was excluded using an autologous pericardial patch, followed by a double-layer linear aneurysmorrhaphy to obliterate the cavity. The patient had an uneventful postoperative course and was discharged on day 9. This case demonstrates that a combined approach-aneurysm exclusion via pericardial patch and concomitant edge-to-edge mitral valve repair-provides a durable, safe solution for SLVA. This strategy effectively eliminates the embolic source and restores valvular competence without compromising left ventricular function.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02212-w.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1098-1102"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13438043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kanandya Kizzandy, Yehezkiel Gian Pradipta Pahu, Satria Rafi Ratmandhika, Krisanto Tanjaya, Elsafira Rana Rinanada, Muhammad Yusuf, Muhammad Reva Aditya, Imam Suseno Bayuadi
{"title":"Transcatheter versus surgical aortic valve replacement for severe aortic stenosis in low-risk adults: a network meta-analysis.","authors":"Kanandya Kizzandy, Yehezkiel Gian Pradipta Pahu, Satria Rafi Ratmandhika, Krisanto Tanjaya, Elsafira Rana Rinanada, Muhammad Yusuf, Muhammad Reva Aditya, Imam Suseno Bayuadi","doi":"10.1007/s12055-026-02245-1","DOIUrl":"10.1007/s12055-026-02245-1","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the safety and efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in low-risk severe aortic stenosis, and to assess the differential impact of balloon-expandable (BE) and self-expanding (SE) valve platforms on clinical outcomes.</p><p><strong>Methods: </strong>A systematic search across seven databases was performed through May 2024. Frequentist and Bayesian network meta-analyses were conducted across three pre-specified time horizons: 30 days, 1 to 2 years, and 3 or more years. Results are reported as odds ratios (OR) with 95% confidence intervals (CI). Egger's regression testing and randomized controlled trial (RCT)-only sensitivity analyses were performed.</p><p><strong>Results: </strong>Thirty-one studies (37,741 patients) were included. All TAVR types demonstrated comparable short-term and intermediate-term mortality to SAVR, with TAVR-BE ranking most favourably by Surface Under the Cumulative Ranking (SUCRA) (81.2% and 87.7%); these rankings should be interpreted alongside the non-significant effect estimates. In exploratory ≥3-year analyses (k=10 studies, consistent with RCT-only sensitivity analyses), TAVR-Mixed showed significantly higher mortality than SAVR (OR 1.963 [95% CI 1.620 to 2.378]; p<0.001), while TAVR-BE and TAVR-SE showed no significant difference. TAVR-BE significantly reduced 30-day rehospitalization (OR 0.625; p=0.007), stroke (OR 0.534; p=0.001), atrial fibrillation, acute kidney injury, and major bleeding versus SAVR. All TAVR platforms shortened hospital stay by approximately 4 days. SAVR was associated with significantly lower rates of paravalvular regurgitation and permanent pacemaker implantation at all time horizons.</p><p><strong>Conclusion: </strong>In low-risk severe aortic stenosis, TAVR, particularly with balloon-expandable valves, appears to offer comparable short-term and intermediate-term survival with superior procedural safety versus SAVR. In exploratory ≥3-year analyses, SAVR was associated with lower mortality specifically within the heterogeneous TAVR-Mixed cohort; TAVR-BE and TAVR-SE showed no significant mortality difference from SAVR at this horizon, underscoring the importance of platform-specific and individualised decision-making.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12055-026-02245-1.</p>","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1066-1088"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"AI can write the paper-but whose paper is it?","authors":"Pradeep Narayan","doi":"10.1007/s12055-026-02262-0","DOIUrl":"10.1007/s12055-026-02262-0","url":null,"abstract":"","PeriodicalId":13285,"journal":{"name":"Indian Journal of Thoracic and Cardiovascular Surgery","volume":"42 9","pages":"1021-1022"},"PeriodicalIF":0.6,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13437816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}